Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) Return on Assets (2017 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Return on Assets for 5 consecutive years, with 0.64% as the latest value for Q3 2021.

  • Quarterly Return on Assets rose 284.0% to 0.64% in Q3 2021 from the year-ago period, while the trailing twelve-month figure was 0.64% through Sep 2021, up 284.0% year-over-year, with the annual reading at 1.47% for FY2020, 38.0% up from the prior year.
  • Return on Assets for Q3 2021 was 0.64% at ENDRA Life Sciences, down from 0.61% in the prior quarter.
  • The five-year high for Return on Assets was 0.49% in Q3 2017, with the low at 6.06% in Q1 2017.
  • Average Return on Assets over 5 years is 2.23%, with a median of 2.3% recorded in 2018.
  • Peak annual rise in Return on Assets hit 454bps in 2018, while the deepest fall reached -400bps in 2018.
  • Over 5 years, Return on Assets stood at 0.79% in 2017, then plummeted by -191bps to 2.3% in 2018, then decreased by -7bps to 2.47% in 2019, then soared by 33bps to 1.66% in 2020, then skyrocketed by 62bps to 0.64% in 2021.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.64%, 0.61%, and 0.77% for Q3 2021, Q2 2021, and Q1 2021 respectively.